We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CORT market cap is 7.01B. The company's latest EPS is USD 1.0130 and P/E is 66.00.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 123.6M | 135.41M | 146.81M | 163.8M | 182.55M |
| Operating Income | 31.18M | 31.67M | 29.5M | 35.59M | 46.6M |
| Net Income | 31.38M | 31.36M | 27.76M | 35.49M | 47.21M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 306.49M | 353.87M | 365.98M | 401.86M | 482.38M |
| Operating Income | 111.61M | 128.2M | 124.48M | 98.63M | 107.28M |
| Net Income | 94.18M | 106.01M | 112.51M | 101.42M | 106.14M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 594.02M | 621.52M | 655.94M | 714.56M | 784.26M |
| Total Liabilities | 132.34M | 114.81M | 108.07M | 118.31M | 145.42M |
| Total Equity | 461.68M | 506.71M | 547.86M | 596.24M | 638.84M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 412.31M | 571.73M | 423.76M | 583.43M | 621.52M |
| Total Liabilities | 41.13M | 48.39M | 47.95M | 81.59M | 114.81M |
| Total Equity | 371.18M | 523.34M | 375.81M | 501.84M | 506.71M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 121.15M | 127.04M | 23.76M | 64.94M | 138.77M |
| Investing | 73.81M | 90.91M | -9.01M | -69.21M | -113.24M |
| Financing | -149.49M | -148.72M | -543k | -2.69M | -23.79M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 136.12M | 151.97M | 167.89M | 120.32M | 127.04M |
| Investing | -117.83M | -119.26M | 136.13M | -114.33M | 90.91M |
| Financing | -28.65M | 12.21M | -302.59M | -17.28M | -148.72M |
| Market Cap | 7.01B |
| Price to Earnings Ratio | 66.00 |
| Price to Sales Ratio | 14.52 |
| Price to Cash Ratio | 51.68 |
| Price to Book Ratio | 13.83 |
| Dividend Yield | - |
| Shares Outstanding | 104.78M |
| Average Volume (1 week) | 1.1M |
| Average Volume (1 Month) | 906.83k |
| 52 Week Change | 210.06% |
| 52 Week High | 71.29 |
| 52 Week Low | 20.84 |
| Spread (Intraday) | 5.5 (7.97%) |
| Company Name | Corcept Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.corcept.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
